ClinicalTrials.gov
public full text
Public Domain
Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels
The main objective of the study is to analyse the role of a neurotrophic factor (BDNF) as a putative biological marker of the cognitive recovery in schizophrenia following a Cognitive Remediation Therapy (CRT). Additionally, the role as outcome predictors of BDNF serum levels and the Val66met polymorphism and data from functional and structural neuroimaging will be studied.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia#1102867
- The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia#908609
- Short-term exposure to enriched environment in adult rats restores MK-801-induced cognitive deficits and gabaergic interneuron immunoreactivity loss#948390
- Cognitive REmediation After Trauma Exposure Trial = CREATE Trial#1114627
- LRFN5 and OLFM4 in Schizophrenia#1087502
Record · ID 1137918
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive